Healthcare

ISPOR’s Oncology and Statistical Methods Special Interest Groups Selects DistillerSR for Joint Systematic Review Project

Leading Pharmaceutical Manufacturers, Contract Research Organizations, and Academic Medical Centers Collaborate on Global Research Project Using DistillerSR. OTTAWA, ONTARIO /…

4 months ago

iTolerance, Inc. Appoints Former Chief of the Laboratory of Biochemistry in the FDA’s Center for Drug Evaluation and Research (CDER), Emily Shacter, Ph.D., to its Scientific Advisory Board

Esteemed expert in the regulation and development of biopharmaceuticals, with more than three decades of experience spanning government, industry, and…

4 months ago

Allied OMS Partners with Oral Surgery Michiana to Bring Doctor-Led Model to Indiana

SOUTHLAKE, TX and SOUTH BEND, IN / ACCESS Newswire / August 21, 2025 / Allied OMS, the nation's leading doctor-owned…

4 months ago

Wisconsin’s Only DOL-OWCP Clinic Leads the Fight for Injured Workers in Wisconsin

Advanced Care Specialists is Bringing Not Just Medical Care, but True Advocacy RACINE, WISCONSIN / ACCESS Newswire / August 21,…

4 months ago

Adia Nutrition Launches Second National Television Campaign Showcasing U.S.-Based Regenerative Stem Cell Therapies

Winter Park, Florida--(Newsfile Corp. - August 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative…

4 months ago

NaphCare Launches Specialized EHR Solution for Georgia Department of Corrections

NaphCare and the Georgia Department of Corrections successfully implemented TechCare 5.0 EHR to serve incarcerated populations and enhance patient care…

4 months ago

NaphCare Launches Specialized EHR Solution for Georgia Department of Corrections

NaphCare and the Georgia Department of Corrections successfully implemented TechCare 5.0 EHR to serve incarcerated populations and enhance patient care…

4 months ago

Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia’s Indication to Treatment of General Diarrhea in Dogs

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia®-CA1, is conditionally approved by the FDA for treatment of CID in dogsCompany…

4 months ago

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY /…

4 months ago